Statistics for CytoDyn (id:11203 CYDY)
Valuation metrics
Market cap
146.38M
Enterprise value
152.09M
Trailing P/E (ttm)
-2.40
Forward P/E
-0.67
PEG ratio
-0.67
Price/Sales (ttm)
Price/Book (mrq)
-1.60
Enterprise Value/Revenue
Enterprise Value/EBITDA
-9.52
Overview
Shares outstanding
1.22B
Float
1.22B
Shares short
% Held by insiders
0.01%
% Held by institutions
0.00%
Average volume (10 days)
2.53M
Average volume (90 days)
Price summary
52-Week low
0.11
52-Week high
0.42
52-Week change
-50.00%
Beta
0.16
50-Day moving average
0.14
200-Day moving average
0.15
Dividends and splits
Forward annual dividend rate
Forward annual dividend yield
Trailing annual dividend rate
0.00%
Trailing annual dividend yield
0.00
5-Year annual dividend yield
Payout ratio
0.00
Dividend date
Ex-dividend date
Last split factor
2:1
Last split date
Financials
Fiscal yearFiscal year ends
May 31th, 2024
Most recent quarter (mrq)
August 31th, 2024
Profitability
Profit margin
0.00%
Operating margin
0.00%
Operational effectiveness
Return on assets
-49.45%
Return on equity
43.96%
Income statement
Revenue (ttm)
0.00
Revenue per share (ttm)
0.00
Quarterly revenue growth (yoy)
Gross profit (ttm)
0.00
EBITDA
-15,970,000.00
Net income to common (ttm)
-20,525,000.00
Diluted EPS (ttm)
-0.02
Quarterly earnings growth (yoy)
Balance sheet
Total cash (mrq)
24.92M
Total cash per share (mrq)
0.02
Total debt (mrq)
29.16M
Total Debt/Equity (mrq)
-0.34
Current ratio (mrq)
39.90%
Book value per share (mrq)
-0.07
Cash flow
Cash flow statement
-1,047,000.00
Levered free cash flow (LFCF)
-59,493,624.00